Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:31 PM View:  | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 15-Nov-24 | Sale (Planned) | 31,897 | $0.39 | $12,583.40 | (3%) 1.03M to 993.92K | |
| 16-Oct-24 4:54 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 15-Oct-24 | Sale (Planned) | 31,897 | $0.56 | $17,926.10 | (3%) 1.06M to 1.03M | |
| 08-Oct-24 4:44 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 67,695 | $0.57 | $38,328.90 | (13%) 519.75K to 452.06K | |
| 08-Oct-24 4:44 PM View: | Baldry Mark Chief Commercial Officer | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 11,127 | $0.58 | $6,505.96 | (19%) 59.64K to 48.51K | |
| 08-Oct-24 4:44 PM View: | Taveras Arthur Chief Scientific Officer | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 76,920 | $0.56 | $43,306.00 | (17%) 464.95K to 388.03K | |
| 08-Oct-24 4:44 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 230,645 | $0.55 | $126,901.00 | (100%) 230.65K to 0 | |
| 08-Oct-24 4:44 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 239,436 | $0.55 | $131,522.00 | (18%) 1.3M to 1.06M | |
| 08-Oct-24 4:44 PM View: | Baldry Mark Chief Commercial Officer | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 34,946 | -- | -- | 142% 24.69K to 59.64K | |
| 08-Oct-24 4:44 PM View: | Taveras Arthur Chief Scientific Officer | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 230,645 | -- | -- | 98% 234.3K to 464.95K | |
| 08-Oct-24 4:44 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 230,645 | -- | -- | 100% 0 to 230.65K | |
| 08-Oct-24 4:44 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 532,081 | -- | -- | 70% 765.07K to 1.3M | |
| 08-Oct-24 4:44 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 230,645 | -- | -- | 80% 289.11K to 519.75K | |
| 11-Sep-24 4:01 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 09-Sep-24 | Sale | 2,642 | $0.66 | $1,737.64 | (< 1%) 291.75K to 289.11K | |
| 11-Jun-24 4:13 PM View: | Stewart Murray Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 31% 146.5K to 191.5K | |
| 11-Jun-24 4:13 PM View: | McGirr David W J Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 87% 51.67K to 96.67K | |
| 11-Jun-24 4:13 PM View: | de Craecker Francoise Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 87% 51.67K to 96.67K | |
| 11-Jun-24 4:13 PM View: | Aliski William Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 87% 51.67K to 96.67K | |
| 11-Jun-24 4:12 PM View: | Woods Keith Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 50% 90.0K to 135.0K | |
| 11-Jun-24 4:12 PM View: | Wyzga Michael S Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 59% 76.67K to 121.67K | |
| 11-Jun-24 4:12 PM View: | Bridger Gary Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 87% 51.67K to 96.67K | |
| 11-Jun-24 4:12 PM View: | Lawton Alison Francis Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 87% 51.67K to 96.67K | |
| 11-Mar-24 5:19 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 52,500 | $0.88 | $46,347.00 | (100%) 52.5K to 0 | |
| 11-Mar-24 5:20 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 49,678 | $0.88 | $43,855.70 | (6%) 814.75K to 765.07K | |
| 11-Mar-24 5:19 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 15,409 | $0.88 | $13,590.70 | (5%) 307.16K to 291.75K | |
| 11-Mar-24 5:20 PM View: | Taveras Arthur Chief Scientific Officer | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 14,235 | $0.88 | $12,552.40 | (6%) 248.54K to 234.3K | |
| 12-Feb-24 5:23 PM View: | Taveras Arthur Chief Scientific Officer | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale | 787 | $1.01 | $792.67 | (< 1%) 249.32K to 248.54K | |
| 12-Feb-24 5:03 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale (Planned) | 27,721 | $1.01 | $27,973.30 | (35%) 80.22K to 52.5K | |
| 12-Feb-24 5:05 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale (Planned) | 21,695 | $1.01 | $21,892.40 | (3%) 836.44K to 814.75K | |
| 12-Feb-24 5:23 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale | 3,683 | $1.01 | $3,708.78 | (1%) 310.84K to 307.16K | |
| 03-Nov-23 5:26 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 03-Nov-23 | Sale (Planned) | 39,906 | $0.90 | $35,915.40 | (5%) 876.35K to 836.44K | |
| 03-Nov-23 5:26 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 199,531 | $0.73 | $145,658.00 | (19%) 1.08M to 876.35K | |
| 03-Nov-23 4:39 PM View: | Taveras Arthur Chief Scientific Officer | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 67,695 | $0.73 | $49,417.40 | (21%) 317.02K to 249.32K | |
| 03-Nov-23 4:42 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 230,645 | $0.73 | $168,371.00 | (74%) 310.87K to 80.22K | |
| 03-Nov-23 4:40 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 67,695 | $0.73 | $49,417.40 | (18%) 378.54K to 310.84K | |
| 03-Nov-23 4:39 PM View: | Baldry Mark Chief Commercial Officer | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 10,257 | $0.73 | $7,487.61 | (29%) 34.95K to 24.69K | |
| 02-Nov-23 4:58 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 532,081 | -- | -- | 98% 543.8K to 1.08M | |
| 02-Nov-23 4:59 PM View: | Taveras Arthur Chief Scientific Officer | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 230,645 | -- | -- | 267% 86.37K to 317.02K | |
| 02-Nov-23 5:00 PM View: | Baldry Mark Chief Commercial Officer | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 34,947 | -- | -- | 100% 0 to 34.95K | |
| 02-Nov-23 5:04 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 230,645 | -- | -- | 288% 80.22K to 310.87K | |
| 02-Nov-23 4:55 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 230,645 | -- | -- | 156% 147.89K to 378.54K | |
| 18-Oct-23 4:02 PM View: | Woods Keith Director | X4 Pharmaceuticals, Inc (XFOR) | 16-Oct-23 | Grant | 90,000 | -- | -- | 100% 0 to 90.0K | |
| 12-Sep-23 4:04 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 08-Sep-23 | Sale (Planned) | 2,642 | $1.25 | $3,299.86 | (2%) 150.54K to 147.89K | |
| 22-Aug-23 4:09 PM View: | Wyzga Michael S Director | X4 Pharmaceuticals, Inc (XFOR) | 18-Aug-23 | Private Purchase | 25,000 | $1.20 | $29,875.00 | 48% 51.67K to 76.67K | |
| 11-Aug-23 7:26 PM View: | Stewart Murray Interim Chief Medical Officer Director | X4 Pharmaceuticals, Inc (XFOR) | 10-Aug-23 | Sale | 130,056 | $1.06 | $137,859.00 | (47%) 276.56K to 146.5K | |
| 11-Aug-23 7:26 PM View: | Stewart Murray Interim Chief Medical Officer Director | X4 Pharmaceuticals, Inc (XFOR) | 09-Aug-23 | Grant | 269,893 | -- | -- | 4048% 6.67K to 276.56K | |
| 05-Jul-23 4:04 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-23 | Market Sale (Planned) | 2,641 | $1.89 | $4,991.49 | (3%) 82.86K to 80.22K | (12%) |
| 05-Jul-23 4:05 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-23 | Market Sale (Planned) | 464 | $1.89 | $876.96 | (< 1%) 151.0K to 150.54K | (12%) |
| 26-Jun-23 4:15 PM View: | Dibiase Mary Chief Operating Officer | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-23 | Market Sale (Planned) | 857 | $1.93 | $1,654.01 | (< 1%) 151.86K to 151.0K | (10%) |
| 26-Jun-23 4:13 PM View: | Mostafa Adam S. Chief Financial Officer | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-23 | Market Sale (Planned) | 5,417 | $1.93 | $10,454.80 | (6%) 88.28K to 82.86K | (10%) |
| 26-Jun-23 4:11 PM View: | Ragan Paula President and CEO Director | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-23 | Market Sale (Planned) | 6,724 | $1.92 | $12,910.10 | (1%) 550.52K to 543.8K | (10%) |
